US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 1.370
  • +0.020+1.48%
Close Feb 14 16:00 ET
  • 1.310
  • -0.060-4.38%
Post 20:01 ET
88.01MMarket Cap-0.88P/E (TTM)

About Inozyme Pharma Company

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.

Company Profile

SymbolINZY
Company NameInozyme Pharma
Listing DateJul 24, 2020
Issue Price16.00
Founded2015
CEODr. Douglas A. Treco, PhD
MarketNASDAQ
Employees59
Fiscal Year Ends12-31
Address321 Summer Street,Suite 400
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-330-4340
Websitehttp://www.inozyme.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Douglas A. Treco, PhD
  • Chairman of the Board and Chief Executive Officer
  • 5.30M
  • Matthew Winton
  • Chief Operations Officer
  • 1.55M
  • Sanjay Subramanian
  • Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
  • 1.03M
  • Erik Harris
  • Director
  • --
  • Axel Bolte
  • Director
  • 1.80M
  • Reinaldo M. Diaz
  • Lead Independent Director
  • 130.27K
  • Edward T. Mathers
  • Independent Director
  • 116.15K
  • Dr. Sarah Bhagat, PhD
  • Independent Director
  • 114.65K
  • Dr. Martin William Edwards, M.D.
  • Independent Director
  • 129.65K
  • Dr. Robert Hopfner, M.B.A.,PhD,R.Ph.
  • Independent Director
  • 112.15K
  • Lynne Sullivan
  • Independent Director
  • 122.15K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!